K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Kilitch Drugs (India) Ltd
NSE:KILITCH
Price:
152.7
INR
-51.31%
Market Closed
Market Cap:
₹5.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Kilitch Drugs (India) Ltd
NSE:KILITCH
|
IN |
|
M
|
Mitsubishi Pencil Co Ltd
TSE:7976
|
JP |
|
S
|
Shinkong Synthetic Fiber Corp
TWSE:1409
|
TW |
|
A
|
Ai Robotics Inc
TSE:247A
|
JP |
|
E
|
Enel Americas SA
SGO:ENELAM
|
CL |
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
|
Nava Limited
NSE:NAVA
|
IN |
|
Nippon Avionics Co Ltd
TSE:6946
|
JP |
|
Yokogawa Electric Corp
TSE:6841
|
JP |
|
K
|
Kim Heng Ltd
SGX:5G2
|
SG |
|
P
|
Pelayaran Nasional Ekalya Purnamasari Tbk PT
IDX:ELPI
|
ID |
Relative Value
The Relative Value of one KILITCH stock under the Base Case scenario is hidden INR. Compared to the current market price of 152.7 INR, Kilitch Drugs (India) Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
KILITCH Relative Value
HIDDEN
Multiples Across Competitors
KILITCH Competitors Multiples
Kilitch Drugs (India) Ltd Competitors
Kilitch Drugs (India) Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
K
|
Kilitch Drugs (India) Ltd
NSE:KILITCH
|
5.5B INR | 1.3 | 10.1 | 18.7 | 21.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.3 | 42.1 | 28.4 | 30.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6.2 | 21.7 | 15 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.6 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
